• Poster presentation
  • P-230

Functional outcome improvements in spinal muscle atrophy (SMA) after onasemnogene abeparvovec: a 1 year follow-up trend

Appointment

Date:
Time:
Talk time:
Discussion time:
Location / Stream:
Exhibition hall A & B

Topic

  • Neuromuscular disorders